Development and Characterisation of Gastroretentive Solid Dosage Form Based on Melt Foaming

Gábor Vasvári, Ádám Haimhoffer, László Horváth, István Budai, György Trencsényi, Monika Béresová, Csaba Dobó-Nagy, J. Váradi, I. Bácskay, Zoltán Ujhelyi, Pálma Fehér, Dávid Sinka, M. Vecsernyés, Ferenc Fenyvesi

Research output: Contribution to journalArticle

Abstract

Dosage forms with increased gastric residence time are promising tools to increase bioavailability of drugs with narrow absorption window. Low-density floating formulations could avoid gastric emptying; therefore, sustained drug release can be achieved. Our aim was to develop a new technology to produce low-density floating formulations by melt foaming. Excipients were selected carefully, with the criteria of low gastric irritation, melting range below 70°C and well-known use in oral drug formulations. PEG 4000, Labrasol and stearic acid type 50 were used to create metronidazole dispersion which was foamed by air on atmospheric pressure using in-house developed apparatus at 53°C. Stearic acid was necessary to improve the foamability of the molten dispersion. Additionally, it reduced matrix erosion, thus prolonging drug dissolution and preserving hardness of the moulded foam. Labrasol as a liquid solubiliser can be used to increase drug release rate and drug solubility. Based on the SEM images, metronidazole in the molten foam remained in crystalline form. MicroCT scans with the electron microscopic images revealed that the foam has a closed-cell structure, where spherical voids have smooth inner wall, they are randomly dispersed, while adjacent voids often interconnected with each other. Drug release from all compositions followed Korsmeyer-Peppas kinetic model. Erosion of the matrix was the main mechanism of the release of metronidazole. Texture analysis confirmed that stearic acid plays a key role in preserving the integrity of the matrix during dissolution in acidic buffer. The technology creates low density and solid matrix system with micronsized air-filled voids.

Original languageEnglish
Article number290
JournalAAPS PharmSciTech
Volume20
Issue number7
DOIs
Publication statusPublished - Oct 1 2019

Fingerprint

Dosage Forms
Metronidazole
Stomach
Air
Technology
X-Ray Microtomography
Drug Compounding
Atmospheric Pressure
Excipients
Gastric Emptying
Hardness
Pharmaceutical Preparations
Solubility
Freezing
Biological Availability
Buffers
Electrons
Drug Liberation
stearic acid
Labrasol

Keywords

  • gastric retention
  • lipid matrix
  • PEG 4000
  • solid dispersion
  • solid foam

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Vasvári, G., Haimhoffer, Á., Horváth, L., Budai, I., Trencsényi, G., Béresová, M., ... Fenyvesi, F. (2019). Development and Characterisation of Gastroretentive Solid Dosage Form Based on Melt Foaming. AAPS PharmSciTech, 20(7), [290]. https://doi.org/10.1208/s12249-019-1500-2

Development and Characterisation of Gastroretentive Solid Dosage Form Based on Melt Foaming. / Vasvári, Gábor; Haimhoffer, Ádám; Horváth, László; Budai, István; Trencsényi, György; Béresová, Monika; Dobó-Nagy, Csaba; Váradi, J.; Bácskay, I.; Ujhelyi, Zoltán; Fehér, Pálma; Sinka, Dávid; Vecsernyés, M.; Fenyvesi, Ferenc.

In: AAPS PharmSciTech, Vol. 20, No. 7, 290, 01.10.2019.

Research output: Contribution to journalArticle

Vasvári, G, Haimhoffer, Á, Horváth, L, Budai, I, Trencsényi, G, Béresová, M, Dobó-Nagy, C, Váradi, J, Bácskay, I, Ujhelyi, Z, Fehér, P, Sinka, D, Vecsernyés, M & Fenyvesi, F 2019, 'Development and Characterisation of Gastroretentive Solid Dosage Form Based on Melt Foaming', AAPS PharmSciTech, vol. 20, no. 7, 290. https://doi.org/10.1208/s12249-019-1500-2
Vasvári G, Haimhoffer Á, Horváth L, Budai I, Trencsényi G, Béresová M et al. Development and Characterisation of Gastroretentive Solid Dosage Form Based on Melt Foaming. AAPS PharmSciTech. 2019 Oct 1;20(7). 290. https://doi.org/10.1208/s12249-019-1500-2
Vasvári, Gábor ; Haimhoffer, Ádám ; Horváth, László ; Budai, István ; Trencsényi, György ; Béresová, Monika ; Dobó-Nagy, Csaba ; Váradi, J. ; Bácskay, I. ; Ujhelyi, Zoltán ; Fehér, Pálma ; Sinka, Dávid ; Vecsernyés, M. ; Fenyvesi, Ferenc. / Development and Characterisation of Gastroretentive Solid Dosage Form Based on Melt Foaming. In: AAPS PharmSciTech. 2019 ; Vol. 20, No. 7.
@article{27d2a0576a874e4b8503e7820117d5ba,
title = "Development and Characterisation of Gastroretentive Solid Dosage Form Based on Melt Foaming",
abstract = "Dosage forms with increased gastric residence time are promising tools to increase bioavailability of drugs with narrow absorption window. Low-density floating formulations could avoid gastric emptying; therefore, sustained drug release can be achieved. Our aim was to develop a new technology to produce low-density floating formulations by melt foaming. Excipients were selected carefully, with the criteria of low gastric irritation, melting range below 70°C and well-known use in oral drug formulations. PEG 4000, Labrasol and stearic acid type 50 were used to create metronidazole dispersion which was foamed by air on atmospheric pressure using in-house developed apparatus at 53°C. Stearic acid was necessary to improve the foamability of the molten dispersion. Additionally, it reduced matrix erosion, thus prolonging drug dissolution and preserving hardness of the moulded foam. Labrasol as a liquid solubiliser can be used to increase drug release rate and drug solubility. Based on the SEM images, metronidazole in the molten foam remained in crystalline form. MicroCT scans with the electron microscopic images revealed that the foam has a closed-cell structure, where spherical voids have smooth inner wall, they are randomly dispersed, while adjacent voids often interconnected with each other. Drug release from all compositions followed Korsmeyer-Peppas kinetic model. Erosion of the matrix was the main mechanism of the release of metronidazole. Texture analysis confirmed that stearic acid plays a key role in preserving the integrity of the matrix during dissolution in acidic buffer. The technology creates low density and solid matrix system with micronsized air-filled voids.",
keywords = "gastric retention, lipid matrix, PEG 4000, solid dispersion, solid foam",
author = "G{\'a}bor Vasv{\'a}ri and {\'A}d{\'a}m Haimhoffer and L{\'a}szl{\'o} Horv{\'a}th and Istv{\'a}n Budai and Gy{\"o}rgy Trencs{\'e}nyi and Monika B{\'e}resov{\'a} and Csaba Dob{\'o}-Nagy and J. V{\'a}radi and I. B{\'a}cskay and Zolt{\'a}n Ujhelyi and P{\'a}lma Feh{\'e}r and D{\'a}vid Sinka and M. Vecserny{\'e}s and Ferenc Fenyvesi",
year = "2019",
month = "10",
day = "1",
doi = "10.1208/s12249-019-1500-2",
language = "English",
volume = "20",
journal = "AAPS PharmSciTech",
issn = "1530-9932",
publisher = "American Association of Pharmaceutical Scientists",
number = "7",

}

TY - JOUR

T1 - Development and Characterisation of Gastroretentive Solid Dosage Form Based on Melt Foaming

AU - Vasvári, Gábor

AU - Haimhoffer, Ádám

AU - Horváth, László

AU - Budai, István

AU - Trencsényi, György

AU - Béresová, Monika

AU - Dobó-Nagy, Csaba

AU - Váradi, J.

AU - Bácskay, I.

AU - Ujhelyi, Zoltán

AU - Fehér, Pálma

AU - Sinka, Dávid

AU - Vecsernyés, M.

AU - Fenyvesi, Ferenc

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Dosage forms with increased gastric residence time are promising tools to increase bioavailability of drugs with narrow absorption window. Low-density floating formulations could avoid gastric emptying; therefore, sustained drug release can be achieved. Our aim was to develop a new technology to produce low-density floating formulations by melt foaming. Excipients were selected carefully, with the criteria of low gastric irritation, melting range below 70°C and well-known use in oral drug formulations. PEG 4000, Labrasol and stearic acid type 50 were used to create metronidazole dispersion which was foamed by air on atmospheric pressure using in-house developed apparatus at 53°C. Stearic acid was necessary to improve the foamability of the molten dispersion. Additionally, it reduced matrix erosion, thus prolonging drug dissolution and preserving hardness of the moulded foam. Labrasol as a liquid solubiliser can be used to increase drug release rate and drug solubility. Based on the SEM images, metronidazole in the molten foam remained in crystalline form. MicroCT scans with the electron microscopic images revealed that the foam has a closed-cell structure, where spherical voids have smooth inner wall, they are randomly dispersed, while adjacent voids often interconnected with each other. Drug release from all compositions followed Korsmeyer-Peppas kinetic model. Erosion of the matrix was the main mechanism of the release of metronidazole. Texture analysis confirmed that stearic acid plays a key role in preserving the integrity of the matrix during dissolution in acidic buffer. The technology creates low density and solid matrix system with micronsized air-filled voids.

AB - Dosage forms with increased gastric residence time are promising tools to increase bioavailability of drugs with narrow absorption window. Low-density floating formulations could avoid gastric emptying; therefore, sustained drug release can be achieved. Our aim was to develop a new technology to produce low-density floating formulations by melt foaming. Excipients were selected carefully, with the criteria of low gastric irritation, melting range below 70°C and well-known use in oral drug formulations. PEG 4000, Labrasol and stearic acid type 50 were used to create metronidazole dispersion which was foamed by air on atmospheric pressure using in-house developed apparatus at 53°C. Stearic acid was necessary to improve the foamability of the molten dispersion. Additionally, it reduced matrix erosion, thus prolonging drug dissolution and preserving hardness of the moulded foam. Labrasol as a liquid solubiliser can be used to increase drug release rate and drug solubility. Based on the SEM images, metronidazole in the molten foam remained in crystalline form. MicroCT scans with the electron microscopic images revealed that the foam has a closed-cell structure, where spherical voids have smooth inner wall, they are randomly dispersed, while adjacent voids often interconnected with each other. Drug release from all compositions followed Korsmeyer-Peppas kinetic model. Erosion of the matrix was the main mechanism of the release of metronidazole. Texture analysis confirmed that stearic acid plays a key role in preserving the integrity of the matrix during dissolution in acidic buffer. The technology creates low density and solid matrix system with micronsized air-filled voids.

KW - gastric retention

KW - lipid matrix

KW - PEG 4000

KW - solid dispersion

KW - solid foam

UR - http://www.scopus.com/inward/record.url?scp=85071009405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071009405&partnerID=8YFLogxK

U2 - 10.1208/s12249-019-1500-2

DO - 10.1208/s12249-019-1500-2

M3 - Article

VL - 20

JO - AAPS PharmSciTech

JF - AAPS PharmSciTech

SN - 1530-9932

IS - 7

M1 - 290

ER -